Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sujay Srinivas

Showing results (31-40 of 47) with videos related to

Pageof 5
Sort By:
JCO Global Oncology|May 9, 2024
Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in IndiaJyoti Bajpai, Pritesh Munot, Kishore Kota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2023
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, et al.
Oral Oncology|April 3, 2022
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiationVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Oncology|July 3, 2024
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical TrialVikas Ostwal, Shraddha Patkar, Reena Engineer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral CancerVijay M Patil, Vanita Noronha, Amit Joshi, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
South Asian Journal of Cancer|December 22, 2025
Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi PanelAnant Ramaswamy, Akash Shukla, Reena Engineer, et al.
Journal of Gastrointestinal Cancer|June 5, 2023
Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) StudyVikram Chaudhari, Anant Ramaswamy, Sujay Srinivas, et al.
Pageof 5

Showing results (31-40 of 47) with videos related to

Sort By:
Pageof 5
JCO Global Oncology|May 9, 2024
Evaluation of Metronomic Therapy as a Low-Cost, Sustainable, Standard-of-Care Option in Desmoid Fibromatosis: Real-World Data From a Tertiary Care Center in IndiaJyoti Bajpai, Pritesh Munot, Kishore Kota, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 9, 2023
Trastuzumab Plus Gemcitabine-Cisplatin for Treatment-Naïve Human Epidermal Growth Factor Receptor 2-Positive Biliary Tract Adenocarcinoma: A Multicenter, Open-Label, Phase II Study (TAB)Vikas Ostwal, Sarika Mandavkar, Prabhat Bhargava, et al.
Oral Oncology|April 3, 2022
RMAC study: A randomized study for evaluation of metronomic adjuvant chemotherapy in recurrent head and neck cancers post salvage surgical resection in those who are ineligible for re-irradiationVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Oncology|July 3, 2024
Adjuvant Gemcitabine Plus Cisplatin and Chemoradiation in Patients With Gallbladder Cancer: A Randomized Clinical TrialVikas Ostwal, Shraddha Patkar, Reena Engineer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 21, 2019
Phase I/II Study of Palliative Triple Metronomic Chemotherapy in Platinum-Refractory/Early-Failure Oral CancerVijay M Patil, Vanita Noronha, Amit Joshi, et al.
JCO Global Oncology|March 11, 2026
Carica Papaya Leaf Extract to Improve Chemotherapy-Induced Thrombocytopenia: A Phase III Triple-Blinded, Randomized, Placebo-Controlled, Multicentric TrialVikas Ostwal, Manali Parulekar, Deepali Naughane, et al.
Eclinicalmedicine|May 31, 2019
Phase III Non-inferiority Study Evaluating Efficacy and Safety of Low Dose Gemcitabine Compared to Standard Dose Gemcitabine With Platinum in Advanced Squamous Lung CancerVijay Patil, Vanita Noronha, Amit Joshi, et al.
JAMA Network Open|August 6, 2024
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy: A Phase 3 Randomized Clinical TrialVikas Ostwal, Anant Ramaswamy, Sarika Mandavkar, et al.
South Asian Journal of Cancer|December 22, 2025
Evaluation and Management of Unresectable Hepatocellular Carcinoma: Multidisciplinary Indian Consensus Statements from a Delphi PanelAnant Ramaswamy, Akash Shukla, Reena Engineer, et al.
Journal of Gastrointestinal Cancer|June 5, 2023
Practice Patterns and Survival in Patients with Resected Pancreatic Ductal Adenocarcinomas (PDAC) - Results from the Multicentre Indian Pancreatic & Periampullary Adenocarcinoma Project (MIPPAP) StudyVikram Chaudhari, Anant Ramaswamy, Sujay Srinivas, et al.
Pageof 5